Status:
COMPLETED
Safety and Efficacy of Intrathecally Administered Magnesium Sulfate
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Abdominal Cancer
Abdominal Pain
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Magnesium sulfate safety profile has been documented by histopathological analysis in experimental studies. magnesium sulfate added to local anesthetics decrease postoperative opioid requirements.
Detailed Description
Spinal anesthesia is commonly used for the major abdominal cancer surgery because of decreasing the risks of general anesthesia.The quality and duration of sensory and motor block and decrease post op...
Eligibility Criteria
Inclusion
- patients with ASA physical status II or III, 21-year-old or older with major abdominal cancer surgery
Exclusion
- significant coexisting, hepatorenal, or other end organ disease, obesity (BMI \> 38 kg/m2), contraindication to regional anesthesia and sensitivity to local anesthetic drugs
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03459417
Start Date
January 1 2018
End Date
June 1 2019
Last Update
December 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt
Asyut, Egypt, 0020